日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modelling hepatocellular carcinoma microenvironment phenotype to evaluate drug efficacy

模拟肝细胞癌微环境表型以评估药物疗效

Sara Cherradi #, Salomé Roux #, Marie Dupuy, Séverine Tabone-Eglinger, Edouard Tuaillon, Marianne Ziol, Eric Assenat, Hong Tuan Duong

Discovery of epigenetically silenced tumour suppressor genes in aggressive breast cancer through a computational approach

利用计算方法发现侵袭性乳腺癌中表观遗传沉默的抑癌基因

Vitte, Anne-Laure; Chuffart, Florent; Jacquet, Emmanuelle; Nika, Eleni; Mousseau, Mireille; Jung, Ina; Tabone-Eglinger, Séverine; Bachelot, Thomas; Rousseaux, Sophie; Khochbin, Saadi; Bourova-Flin, Ekaterina

Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma

NeoPembrOv试验的免疫组学纵向分析揭示了高级别卵巢癌免疫耐药的驱动因素

Le Saux, Olivia; Ardin, Maude; Berthet, Justine; Barrin, Sarah; Bourhis, Morgane; Cinier, Justine; Lounici, Yasmine; Treilleux, Isabelle; Just, Pierre-Alexandre; Bataillon, Guillaume; Savoye, Aude-Marie; Mouret-Reynier, Marie-Ange; Coquan, Elodie; Derbel, Olfa; Jeay, Louis; Bouizaguen, Suliman; Labidi-Galy, Intidhar; Tabone-Eglinger, Séverine; Ferrari, Anthony; Thomas, Emilie; Ménétrier-Caux, Christine; Tartour, Eric; Galy-Fauroux, Isabelle; Stern, Marc-Henri; Terme, Magali; Caux, Christophe; Dubois, Bertrand; Ray-Coquard, Isabelle

Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project

肺神经内分泌肿瘤组织病理学分类的现有和新兴标准评估(基于 lungNENomics 项目)

Mathian, É; Drouet, Y; Sexton-Oates, A; Papotti, M G; Pelosi, G; Vignaud, J-M; Brcic, L; Mansuet-Lupo, A; Damiola, F; Altun, C; Berthet, J-P; Fournier, C B; Brustugun, O T; Centonze, G; Chalabreysse, L; de Montpréville, V T; di Micco, C M; Fadel, E; Gadot, N; Graziano, P; Hofman, P; Hofman, V; Lacomme, S; Lund-Iversen, M; Mangiante, L; Milione, M; Muscarella, L A; Perrin, C; Planchard, G; Popper, H; Rousseau, N; Roz, L; Sabella, G; Tabone-Eglinger, S; Voegele, C; Volante, M; Walter, T; Dingemans, A-M; Moonen, L; Speel, E J; Derks, J; Girard, N; Chen, L; Alcala, N; Fernandez-Cuesta, L; Lantuejoul, S; Foll, M

Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibition

CDK4 磷酸化的临床前评估预测胸膜间皮瘤对 CDK4/6 抑制具有高敏感性

Sabine Paternot, Eric Raspé, Clément Meiller, Maxime Tarabichi, Jean-Baptiste Assié, Frederick Libert, Myriam Remmelink, Xavier Bisteau, Patrick Pauwels, Yuna Blum, Nolwenn Le Stang, Séverine Tabone-Eglinger, Françoise Galateau-Sallé, Christophe Blanquart, Jan P Van Meerbeeck, Thierry Berghmans, Did

Added value of whole-exome and RNA sequencing in advanced and refractory cancer patients with no molecular-based treatment recommendation based on a 90-gene panel

对于基于90基因panel尚无分子靶向治疗建议的晚期和难治性癌症患者,全外显子组测序和RNA测序具有附加价值。

Dufresne, Armelle; Attignon, Valéry; Ferrari, Anthony; Tonon, Laurie; Boyault, Sandrine; Tabone-Eglinger, Séverine; Cassier, Philippe; Trédan, Olivier; Corradini, Nadège; Vinceneux, Armelle; Swalduz, Aurélie; Viari, Alain; Chabaud, Sylvie; Pérol, David; Blay, Jean Yves; Saintigny, Pierre

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

恶性胸膜间皮瘤的多组学分析确定了驱动肿瘤间异质性的分子轴和特殊肿瘤特征

Lise Mangiante #, Nicolas Alcala #, Alexandra Sexton-Oates #, Alex Di Genova #, Abel Gonzalez-Perez, Azhar Khandekar, Erik N Bergstrom, Jaehee Kim, Xiran Liu, Ricardo Blazquez-Encinas, Colin Giacobi, Nolwenn Le Stang, Sandrine Boyault, Cyrille Cuenin, Severine Tabone-Eglinger, Francesca Damiola, Cat

A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors

癌症精准医疗试验 MAPPYACTS 中用于治疗复发和难治性肿瘤的儿科患者来源异种移植模型生物样本库

Marques Da Costa, Maria Eugénia; Zaidi, Sakina; Scoazec, Jean-Yves; Droit, Robin; Lim, Wan Ching; Marchais, Antonin; Salmon, Jerome; Cherkaoui, Sarah; Morscher, Raphael J; Laurent, Anouchka; Malinge, Sébastien; Mercher, Thomas; Tabone-Eglinger, Séverine; Goddard, Isabelle; Pflumio, Francoise; Calvo, Julien; Redini, Francoise; Entz-Werlé, Natacha; Soriano, Aroa; Villanueva, Alberto; Cairo, Stefano; Chastagner, Pascal; Moro, Massimo; Owens, Cormac; Casanova, Michela; Hladun-Alvaro, Raquel; Berlanga, Pablo; Daudigeos-Dubus, Estelle; Dessen, Philippe; Zitvogel, Laurence; Lacroix, Ludovic; Pierron, Gaelle; Delattre, Olivier; Schleiermacher, Gudrun; Surdez, Didier; Geoerger, Birgit

Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group

内分泌治疗(阿那曲唑)联合 mTOR 抑制剂(Vistusertib)治疗子宫内膜癌的基于核糖体生物发生的预测性生物标志物:与 GINECO 小组合作开展的 VICTORIA 试验转化研究

Nour-El-Houda Mourksi, Cécile Dalban, Amélie Colombe-Vermorel, Laetitia Odeyer, Valentin Simioni, Jean-Sébastien Frenel, Michel Fabbro, Fernando Bazan, Sophie Abadie-Lacourtoisie, Elodie Coquan, Séverine Martinez, Gwenaelle Garin, Séverine Tabone-Eglinger, Isabelle Treilleux, Sylvie Chabaud, David P

Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort

索拉非尼在分子分选癌症患者中的应用:MOST-Plus 索拉非尼队列的最终分析

Trédan, Olivier; Toulmonde, Maud; Le Tourneau, Christophe; Montane, Laure; Italiano, Antoine; Ray-Coquard, Isabelle; De La Fouchardière, Christelle; Bertucci, François; Gonçalves, Anthony; Gomez-Roca, Carlos; You, Benoit; Attignon, Valéry; Boyault, Sandrine; Cassier, Philippe A; Dufresne, Armelle; Tabone-Eglinger, Séverine; Viari, Alain; Sohier, Emilie; Kamal, Maud; Garin, Gwenaël; Blay, Jean-Yves; Pérol, David